Efferon Jsc
Clinical trials sponsored by Efferon Jsc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device aims to clean blood of burn toxins Results expected Dec 2026 (estimated)
- Blood filter may calm the deadly inflammation of cardiogenic shock Results expected Apr 2027 (estimated)
- Blood filter device aims to tame severe IBD flares Results expected Sep 2027 (estimated)
-
Blood filter may calm the deadly inflammation of cardiogenic shock
Disease control Recruiting nowThis trial tests whether a blood-filtering device called Efferon CT can help people with cardiogenic shock, a life-threatening complication of a heart attack. Cardiogenic shock triggers a massive inflammatory response that can damage organs. The device aims to remove inflammatory…
Sponsor: Efferon JSC • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New blood filter may shield heart surgery patients from organ failure
Disease control Recruiting nowThis study tests a device called Efferon LPS that filters harmful substances from the blood during and after heart surgery. The goal is to see if it can reduce the risk of multiple organ failure, a serious complication. Researchers will enroll 60 adults having heart surgery with …
Sponsor: Efferon JSC • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New blood filter could save lives in severe pancreatitis
Disease control Recruiting nowThis study tests a device called Efferon LPS that filters toxins and inflammatory substances from the blood. It is being given to 150 people with severe acute pancreatitis within 24 hours of ICU admission. The goal is to see if it reduces organ failure and improves outcomes compa…
Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New blood filter could speed recovery for burn victims
Disease control Recruiting nowThis pilot study tests a device called Efferon LPS that filters the blood to remove toxins and inflammatory substances in adults with severe thermal burns. Fifteen participants will receive two filtering sessions, and their outcomes will be compared to a group of similar patients…
Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New device aims to clean blood of burn toxins
Disease control Recruiting nowThis study tests a device called Efferon LPS NEO that filters the blood of children with severe burns to remove harmful substances. The goal is to see if it reduces time in the ICU and improves recovery. Thirty children will receive the treatment and be compared to past cases.
Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC